首页> 外文会议>IEEE Conference on Industrial Electronics and Applications >Positive control of a minimal model of tumor growth with bevacizumab treatment
【24h】

Positive control of a minimal model of tumor growth with bevacizumab treatment

机译:北伐单抗治疗肿瘤生长最小模型的阳性控制

获取原文

摘要

Application of model-based control strategies for physiological control problems, like tumor therapy, may greatly improve the efficiency of clinical treatments. Our aim is to design a positive path tracking controller for a minimal model of tumor growth under angiogenic inhibition with bevacizumab treatment. We extend the dynamics of the system to ensure the positivity of the input, and design path tracking controller after exact linearization is carried out for the extended system. We carry out simulations for different reference signals for the path tracking controllers, and confirm that the tumor can be eliminated using bevacizumab therapy with physiologically feasible input signals. The resulting inputs are positive, and their maximal values are in physiologically feasible regions, thus the results may be applicable in clinical practice.
机译:基于模型的控制策略在肿瘤治疗等生理控制问题的应用可能大大提高临床治疗的效率。我们的目的是设计一种正面路径跟踪控制器,用于血管生成抑制下肿瘤生长模型的态度型号。我们扩展了系统的动态,以确保输入的输入和设计路径跟踪控制器在对扩展系统执行精确线性化之后。我们对路径跟踪控制器进行不同参考信号进行模拟,并确认肿瘤可以使用具有生理上可行的输入信号的Bevacizumab治疗来消除。得到的输入是阳性的,并且它们的最大值在生理上可行的区域中,因此结果可能适用于临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号